Trademarkia Logo

Canada

C$
XAVIANCE
ABANDONED SECTION 36

on 9 Dec 2020

Last Applicant/ Owned by

PFIZER INC.

235 East 42nd StreetNew York, NY 10017

US

Serial Number

1826229 filed on 8th Mar 2017

Correspondent Address

TORYS LLP

SUITE 300079 WELLINGTON ST. W.BOX 270, TD CENTRETORONTO

ONTARIO

CA

M5K1N2

XAVIANCE

Trademark usage description

pharmaceutical preparations for the prevention and treatment of psychiatric diseases, degenerative nerve diseases and brain disorders, namely, mood, a Read More

Classification Information


Class [005]
Pharmaceutical preparations for the prevention and treatment of psychiatric diseases, degenerative nerve diseases and brain disorders, namely, mood, anxiety and cognitive disorders, Alzheimer's disease, cerebral palsy, Parkinson's disease, Huntington's disease and multiple sclerosis; Pharmaceutical preparations for the prevention and treatment of cranial and facial nerve disorders, connective tissue injuries, diseases and disorders, bone and cartilage injuries, diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neuromuscular and neurological diseases and disorders, namely, central nervous system diseases and disorders, namely central nervous system infections, brain diseases, central nervous system movement disorders, muscle diseases and disorders, namely inflammatory muscle diseases and disorders, and muscular dystrophy, ocular motility and spinal cord infections, injuries and diseases, and seizure disorders; Pharmaceutical preparations for the prevention and treatment of genitourinary diseases, namely, inflammatory pelvic diseases, urological and reproductive system diseases, disorders and infections, namely, sexually transmitted diseases, erectile and sexual dysfunction, infertility and incontinence; Pharmaceutical preparations for the prevention and treatment of auto-immune, cardiovascular, gastrointestinal, hematologic, oncological, ophthalmological and respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of allergies, hypertension, menopause, diabetic neuropathy, arthritis, and pain; Antibiotics, anti-infectives, anti-inflammatories, anti-fungals, anti-virals, oral and injectable pharmaceutical contraceptives, human vaccines; Pharmaceutical preparations for the prevention and treatment of smoking habits and addictions; Pharmaceutical preparations for the prevention and treatment of renal disease and disorders; Pharmaceutical preparations for the prevention and treatment of diseases, disorders and infections of the endocrine system, namely growth and thyroid disorders; Pharmaceutical preparations for the prevention and treatment of muscular atrophy; Pharmaceutical preparations for the prevention and treatment of inflammatory diseases, namely inflammatory bowel diseases, inflammatory joint diseases, inflammatory connective tissue diseases, inflammatory muscle diseases and disorders; Pharmaceutical preparations for the prevention and treatment of metabolic diseases and disorders, namely diabetes, hypoglycemia, muscular dystrophy, sickle cell disease, and anemia.


Classification kind code

11

Mark Details


Serial Number

1826229

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 14
on 21st Sept 2020
Default Notice Sent
Submitted for opposition 50
on 6th Jul 2018
Allowed
Submitted for opposition 51
on 6th Jul 2018
Allowance Notice Sent
Submitted for opposition 42
on 21st Mar 2018
Advertised
Submitted for opposition 26
on 1st Mar 2018
Approved
Submitted for opposition 22
on 8th Jan 2018
Search Recorded
Submitted for opposition 27
on 8th Jan 2018
Approval Notice Sent
Submitted for opposition 31
on 10th Mar 2017
Formalized
Submitted for opposition 30
on 8th Mar 2017
Filed
Submitted for opposition 1
on 8th Mar 2017
Created